Citing ‘less-than-optimal’ outcomes for Roche’s Evrysdi, Biogen launches high-dose Spinraza trial September 15, 2021 Auto Bot News 0 Citing ‘less-than-optimal’ outcomes for Roche’s Evrysdi, Biogen launches high-dose Spinraza trial esagonowsky Wed, 09/15/2021 – 09:22
